Robert Grimshaw

1.7k total citations
23 papers, 869 citations indexed

About

Robert Grimshaw is a scholar working on Reproductive Medicine, Epidemiology and Surgery. According to data from OpenAlex, Robert Grimshaw has authored 23 papers receiving a total of 869 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Reproductive Medicine, 7 papers in Epidemiology and 6 papers in Surgery. Recurrent topics in Robert Grimshaw's work include Ovarian cancer diagnosis and treatment (10 papers), Cervical Cancer and HPV Research (5 papers) and Intraperitoneal and Appendiceal Malignancies (4 papers). Robert Grimshaw is often cited by papers focused on Ovarian cancer diagnosis and treatment (10 papers), Cervical Cancer and HPV Research (5 papers) and Intraperitoneal and Appendiceal Malignancies (4 papers). Robert Grimshaw collaborates with scholars based in Canada, United Kingdom and United States. Robert Grimshaw's co-authors include John Monaghan, John Murdoch, Elizabeth A. Eisenhauer, Hal W. Hirte, Amit M. Oza, J.F. Jeffrey, Paul Hoskins, Susan Ellard, Gavin Stuart and Lesley Seymour and has published in prestigious journals such as Journal of Clinical Oncology, American Journal of Obstetrics and Gynecology and Annals of Oncology.

In The Last Decade

Robert Grimshaw

23 papers receiving 843 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Robert Grimshaw Canada 16 415 303 246 214 207 23 869
Peter Bryson Canada 12 353 0.9× 250 0.8× 218 0.9× 318 1.5× 215 1.0× 25 817
Abbie L. Fields United States 19 454 1.1× 318 1.0× 488 2.0× 325 1.5× 272 1.3× 43 1.2k
Arto Leminen Finland 23 628 1.5× 249 0.8× 270 1.1× 304 1.4× 348 1.7× 38 1.2k
Giovanni Di Vagno Italy 17 435 1.0× 340 1.1× 370 1.5× 349 1.6× 133 0.6× 52 1.1k
Catherine N. Correa United States 10 323 0.8× 235 0.8× 124 0.5× 152 0.7× 121 0.6× 17 712
Mike F. Janicek United States 16 248 0.6× 198 0.7× 252 1.0× 125 0.6× 247 1.2× 24 847
Sheldon Weiner United States 16 502 1.2× 173 0.6× 444 1.8× 239 1.1× 125 0.6× 29 912
Kristina Hellman Sweden 21 275 0.7× 233 0.8× 319 1.3× 243 1.1× 287 1.4× 55 1.0k
Hyo‐Pyo Lee South Korea 18 341 0.8× 212 0.7× 406 1.7× 94 0.4× 167 0.8× 29 864
Kristin Bixel United States 16 423 1.0× 254 0.8× 366 1.5× 173 0.8× 155 0.7× 70 872

Countries citing papers authored by Robert Grimshaw

Since Specialization
Citations

This map shows the geographic impact of Robert Grimshaw's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Robert Grimshaw with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Robert Grimshaw more than expected).

Fields of papers citing papers by Robert Grimshaw

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Robert Grimshaw. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Robert Grimshaw. The network helps show where Robert Grimshaw may publish in the future.

Co-authorship network of co-authors of Robert Grimshaw

This figure shows the co-authorship network connecting the top 25 collaborators of Robert Grimshaw. A scholar is included among the top collaborators of Robert Grimshaw based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Robert Grimshaw. Robert Grimshaw is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Townsley, Michael & Robert Grimshaw. (2013). The consequences of queueing: Crowding, situational features and aggression in entertainment precincts. Crime Prevention and Community Safety. 15(1). 23–47. 15 indexed citations
2.
Biagi, James, Amit M. Oza, Haji Chalchal, et al.. (2010). A phase II study of sunitinib in patients with recurrent epithelial ovarian and primary peritoneal carcinoma: an NCIC Clinical Trials Group Study. Annals of Oncology. 22(2). 335–340. 101 indexed citations
3.
Hirte, Hal W., Amit M. Oza, K. Swenerton, et al.. (2010). A phase II study of erlotinib (OSI-774) given in combination with carboplatin in patients with recurrent epithelial ovarian cancer (NCIC CTG IND.149). Gynecologic Oncology. 118(3). 308–312. 43 indexed citations
4.
Clarke, Sharon E., et al.. (2009). Risk of Malignancy Index in the Evaluation of Patients With Adnexal Masses. Journal of Obstetrics and Gynaecology Canada. 31(5). 440–445. 27 indexed citations
5.
Grimshaw, Robert. (2009). Lessons in personal efficiency. 1 indexed citations
6.
Grimshaw, Robert, et al.. (2009). Value of targeting at-risk populations at outreach venues: findings from a local sauna. International Journal of STD & AIDS. 20(9). 642–643. 10 indexed citations
7.
Biagi, James, Amit M. Oza, Robert Grimshaw, et al.. (2008). A phase II study of sunitinib (SU11248) in patients (pts) with recurrent epithelial ovarian, fallopian tube or primary peritoneal carcinoma - NCIC CTG IND 185. Journal of Clinical Oncology. 26(15_suppl). 5522–5522. 22 indexed citations
8.
9.
Grimshaw, Robert, et al.. (2005). Complementary and Alternative Medicine in Gynaecologic Oncology. Journal of Obstetrics and Gynaecology Canada. 27(6). 562–568. 22 indexed citations
10.
11.
Johnston, Grace, et al.. (2004). Effectiveness of letters to Cape Breton women who have not had a recent Pap smear.. PubMed. 24(2-3). 49–56. 7 indexed citations
12.
Hirte, Hal, Amit M. Oza, Paul Hoskins, et al.. (2003). 159 Phase II study of OSI-774 given in combination with carboplatin in patients (pts) with recurrent epithelial ovarian cancer (EOC): NCIC ctg Ind.149. European Journal of Cancer Supplements. 1(5). S51–S51. 1 indexed citations
13.
Turner, Robert C., Ronald L. Burkes, Félix Couture, et al.. (2001). Epoetin Alfa in Cancer Patients. Journal of Pain and Symptom Management. 22(5). 954–965. 34 indexed citations
14.
Hoskins, Paul, Elizabeth A. Eisenhauer, Sandra Beare, et al.. (1998). Randomized phase II study of two schedules of topotecan in previously treated patients with ovarian cancer: a National Cancer Institute of Canada Clinical Trials Group study.. Journal of Clinical Oncology. 16(6). 2233–2237. 142 indexed citations
15.
Grimshaw, Robert, John Murdoch, & John Monaghan. (1993). Radical vulvectomy and bilateral inguinal-femoral lymphadenectomy through separate incisions— experience with 100 cases. International Journal of Gynecological Cancer. 3(1). 18–23. 48 indexed citations
16.
Grimshaw, Robert, et al.. (1993). Simultaneous sampling of the endocervix and ectocervix using the profile brush.. PubMed. 37(4). 472–6. 3 indexed citations
17.
Murdoch, John, Robert Grimshaw, P. R. Morgan, & John Monaghan. (1992). The impact of loop diathermy on management of early invasive cervical cancer. International Journal of Gynecological Cancer. 2(3). 129–133. 25 indexed citations
18.
Grimshaw, Robert, et al.. (1990). Prognostic value of peritoneal cytology in endometrial carcinoma. Gynecologic Oncology. 36(1). 97–100. 85 indexed citations
19.
Grimshaw, Robert, et al.. (1990). Prognostic value of peritoneal cytology in endometrial carcinoma. International Journal of Gynecology & Obstetrics. 33(1). 87–87. 15 indexed citations
20.
Grimshaw, Robert, B.F. Mitchell, & John Challis. (1983). Steroid modulation of pregnenolone to progesterone conversion by human placental cells in vitro. American Journal of Obstetrics and Gynecology. 145(2). 234–238. 24 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Peter Bryson Breakdown of academic impact, for papers by Abbie L. Fields Breakdown of academic impact, for papers by Arto Leminen Breakdown of academic impact, for papers by Giovanni Di Vagno Breakdown of academic impact, for papers by Catherine N. Correa Breakdown of academic impact, for papers by Mike F. Janicek Breakdown of academic impact, for papers by Sheldon Weiner Breakdown of academic impact, for papers by Kristina Hellman Breakdown of academic impact, for papers by Hyo‐Pyo Lee Breakdown of academic impact, for papers by Kristin Bixel
Rankless by CCL
2026